Cargando…
The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy
Several chemotherapeutic options are available for patients with metastatic colorectal cancer (mCRC), making it important to individualize treatment regimens. Individualization requires the clinical application of biomarkers for regimen selection, which is presently insufficient. miRNAs serve an imp...
Autores principales: | Sasaki, Megumi, Ishikawa, Toshiaki, Ishiguro, Megumi, Okazaki, Satoshi, Yamauchi, Shinichi, Kikuchi, Akifumi, Matsuyama, Takatoshi, Kawada, Kenro, Tokunaga, Masanori, Uetake, Hiroyuki, Kinugasa, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100963/ https://www.ncbi.nlm.nih.gov/pubmed/33968205 http://dx.doi.org/10.3892/ol.2021.12749 |
Ejemplares similares
-
PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia
por: Orita, Fukuichiro, et al.
Publicado: (2021) -
Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer
por: Miura, Tomiyuki, et al.
Publicado: (2020) -
Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia
por: Hanaoka, Marie, et al.
Publicado: (2017) -
Minimally Invasive Surgery for Colorectal Cancer
por: Yamauchi, Shinichi, et al.
Publicado: (2021) -
A metastasis‐associated microRNA‐based liquid biopsy signature for risk‐stratification in colorectal cancer: a multicenter cohort study
por: Matsuyama, Takatoshi, et al.
Publicado: (2022)